INDIA PUBLIC: PRIVATE PARTNERSHIP MODELS FOR R&D (INFECTIOUS DISEASES) OPPORTUNITIES AND CONSTRAINTS

Welcome to all Delegates Biotechnology for Pharmaceutical and Health Classification of Biotechnology Conventional Is a technique that makes use of living organism for specific purpose eg: bread/cheese

INTERNATIONAL COLLABORATION. S. Sinha Adviser Department of Biotechnology Ministry of Science & Technology Government of India

INTERNATIONAL COLLABORATION S. Sinha Adviser Department of Biotechnology Ministry of Science & Technology Government of India INDIA S ASSETS Strong pool of scientists and engineers >300,000 institutions

Opportunities unfurling

Opportunities unfurling 10 February 2003 News Image not found or type unknown On 1 January 1995 India became a signatory to World Trade Organisation (WTO). India agreed to implement a product patent regime

National Institute of Virology(NIV), Pune

National Institute of Virology(NIV), Pune Japanese Encephalitis Vaccine Product/Process: Chimeric peptide vaccine candidate against Japanese Encephalitis virus. Application/Uses: Japanese encephalitis

BIO OUTSOURCING ASIA Biopharmaceutical Outsourcing Opportunities and Challenges SEPTEMBER 2008 VOL. 1 ISSUE 3

BIO OUTSOURCING ASIA Biopharmaceutical Outsourcing Opportunities and Challenges SEPTEMBER 2008 VOL. 1 ISSUE 3 Bio Outsourcing Asia TABLE OF CONTENTS September 2008 Vol. 1 Issue 3 CanBiotech Inc. CHINA

Celebrating 30 years of Department of Biotechnology (DBT)

Celebrating 30 years of Department of Biotechnology (DBT) Professor Vijay K. Chaudhary Dr. Amita Gupta Department of Biochemistry University of Delhi South Campus New Delhi-110021 1 Swachhta (Cleanliness)

Course Agenda. Day One

Course Agenda BioImmersion: Biotech for the Non-Scientist A three-day, in-depth course that provides the background required for understanding today s fast-paced biotech marketplace. Beginning with an

Pharmacologyonline 1: (2009) ewsletter Jain et al.

I DIA BIOTECH OLOGY: THREE DECADES OF DEVELOPME T Roopesh Jain *, Susmit Kosta 1, Vishwakira Y. 2 and Archana Tiwari 1 1 Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal, 462 036 India 2 Pirmal Life Sciences

INSTITUT PASTEUR INSTITUT PASTEUR IS A PRIVATE, NON PROFIT, INSTITUTE DEDICATED TO RESEARCH & PUBLIC HEALTH

www.pasteur.fr INSTITUT PASTEUR INSTITUT PASTEUR IS A PRIVATE, NON PROFIT, INSTITUTE DEDICATED TO RESEARCH & PUBLIC HEALTH INSTITUT PASTEUR Created in 1887 by Louis Pasteur 2,700 people working in Paris

Vaccine Cuisine EDIBLE VACCINES. Nina Gloriani Barzaga, M.D.,Ph.D. University of the Philippines Manila

Slide 1 Plant Made Pharmaceuticals EDIBLE VACCINES Vaccine Cuisine Nina Gloriani Barzaga, M.D.,Ph.D. University of the Philippines Manila 3 rd Asian Biotechnology Conference, Manila Nov 9-10, 2006 Slide

India as an Outsourcing Frontier in Biotechnology

1 India as an Outsourcing Frontier in Biotechnology K.V. Subramaniam President & CEO 3 rd Annual Biotech Supply Chain Academy Conference San Francisco Oct 26, 2010 Biotechnology Industry Issues Long gestation

BioIndia News / Updates

BioIndia News / Updates Free, bi-monthly newsletter for India s BioBusiness, BioScience, Regulatory and Clinical News; tracking news/trends in the India biopharmaceutical/pharmaceutical biologics industry

Perspective on China and India as Rapidly Evolving Sources of Biotech Products

Perspective on China and India as Rapidly Evolving Sources of Biotech Products The Japanese Biologics Forum February 16, 2007 Gene Murano, Ph.D. Vice President R.Q.C. Strategic Operations Genentech, Inc.

Opening Remarks of the Chairperson. Decisions

Decisions taken in the 44 th Meeting of the Genetic Engineering Approval Committee (GEAC) held on 14 th July 2004. Opening Remarks of the Chairperson The Chairperson explained that as per the guidelines

Global Pharma and R&D Priorities in India

Global Pharma and R&D Priorities in India Dr. S. R. Rao, Department of Biotechnology Government of India Workshop on Alternate Patent Regime and Access to Health May 25-26, 2009 Beijing, China Today s

NIH-RAID: A ROADMAP Program

NIH-RAID: A ROADMAP Program (Rapid Access to Interventional Development} A Program designed to facilitate the development of new therapeutics The NIH-RAID Pilot Program is intended to reduce some of the

From Bench To Clinic : a personal journey Career Research Advancement Focused Training

From Bench To Clinic : a personal journey Career Research Advancement Focused Training February 13, 2018 Irina Tcherepanova Ph.D. Vice President of Translational Medicine Argos Therapeutics Inc. FDA view

- Selection of Target Molecular for Drug Discovery by Verifications on the Validity of Target Candidates -

University of Tokyo and Astellas Enter Collaborative Research for Target Discovery of New Drugs for Neglected Tropical Diseases Caused by Protozoan Parasites - Selection of Target Molecular for Drug Discovery

Regulatory Issues and Drug Product Approval for Biopharmaceuticals

Regulatory Issues and Drug Product Approval for Biopharmaceuticals Vinod P. Shah, Ph. D. FIP Scientific Secretary Biotech 2007 Southern African Regional and International Regulatory Biotechnology Workshop

Policy and Development of Biotechnology: Bangladesh Perspective. N. Choudhury Bangladesh Academy of Sciences

Policy and Development of Biotechnology: Bangladesh Perspective N. Choudhury Bangladesh Academy of Sciences WCS Recommendation National policies should be adopted that imply consistent and long term support

TICEL Bio Park inaugurated

TICEL Bio Park inaugurated 16 December 2004 News Located in the knowledge corridor of Tamil Nadu (Chennai), TICEL Bio Park Ltd, a biotechnology park, which facilitates research and development activities,

Introduction of Development Center for Biotechnology TAIWAN

Introduction of Development Center for Biotechnology TAIWAN DCB Nonprofit Organization Founded in 1984 Funded Mainly by Ministry of Economic Affairs (MOEA), National Science Council and the Industry 394

Integrated M.Tech. in Biotechnology (B.Tech + M.Tech) programme. Semester 1

Annexure-VI Integrated M.Tech. in Biotechnology (B.Tech + M.Tech) programme Semester 1 CY101/PH102 Engineering Chemistry/ Engineering Physics 3 1 0 4 MA103 Basic Mathematics 3 1 0 4 CS101 Computer Programming-I

ubio Biotechnology Systems Pvt. Ltd.

Affordable, Accurate, Accessible Diagnostics for All Business Profile ubio Biotechnology Systems Pvt. Ltd. XII-111-E/F, Technology Incubation Centre KINFRA Hi-Tech Park, Kalamassery Cochin, Kerala, India

Chapter 10 Analytical Biotechnology and the Human Genome

Chapter 10 Analytical Biotechnology and the Human Genome Chapter Outline Enzyme tests and biosensors DNA-based tests DNA analysis technologies Human genome and genome-based analytical methods 1 Enzyme-based

Bayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms

Bayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms Genomics Bioinformatics HTS Combinatorial chemistry Protein drugs

10. BIOTECHNOLOGY (Code No. 045)

10. BIOTECHNOLOGY (Code No. 045) An unprecedented growth of human knowledge in the field of Biological Sciences coupled with equally significant developments in the field of technology have brought significant

Hawaii Biotech, Inc.

Hawaii Biotech, Inc. Biotechnology in Hawaii and the Workforce Requirements National Association for Workforce Improvement Slide 1 Education David Clements - Director of Vaccine Research UH Hilo 1979 1984

tecnologie dal laboratorio all impresa

Mauro Giacca, MD PhD Director-General ICGEB Trieste-Italy, New Delhi-India, Cape Town-South Africa http://www.icgeb.org International Centre for Genetic Engineering and Biotechnology (ICGEB) giacca@icgeb.org

Monsanto leaking millions in patent revenue, claims Canada

TIGR finishes work on rice genome The Institute for Genomic Research (TIGR) is a non-profit research center based in Rockville, USA dedicated to deciphering and analyzing genomes and molecular chains that

Promoting Women in Science

Promoting Women in Science Initiatives of Department of Biotechnology Department of Biotechnology Ministry of Science & Technology Government of India Department of Biotechnology Set up in 1986 Focus Research

Biotechnology Industry Partnership Programme (BIPP) (An Advanced Technology Scheme)

Biotechnology Industry Partnership Programme (BIPP) (An Advanced Technology Scheme) Department of Biotechnology Ministry of Science & Technology Government of India New Delhi 110 003 For further details

Pharmaceutical Biotechnology

Pharmaceutical Biotechnology Debbie S. Retnoningrum; Catur Riani; Tri Suciati; Heni Rachmawati; Ana Indrayati School of Pharmacy, ITB Introduction 1 REFERENCES Glick, BR and JJ Pasternak, 2003, Molecular

Roche, Roche Molecular Diagnostics and more

, Molecular and more [Monte Wetzel, PhD] Patients have questions. We provide answers. Group Clear focus on Healthcare Innovation with two strong pillars Pharma Pharma Genentech Chugai Molecular Professional

Practical Applications of Immunology (Chapter 18) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College Eastern Campus

Practical Applications of Immunology (Chapter 18) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College Eastern Campus Primary Source for figures and content: Tortora, G.J. Microbiology

EXECUTIVE SUMMARY EXECUTIVE SUMMARY. Global funding for neglected disease R&D increased for the first time since The survey.

The survey Each year since 2007, the G-FINDER project has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development (R&D)

Class XII - Biology Biotechnology and its Applications Chapter-wise Questions

Class XII - Biology Biotechnology and its Applications Chapter-wise Questions MULTIPLE-CHOICE QUESTIONS 1. Bt cotton is not: a. A GM plant b. Insect resistant c. A bacterial gene expressing system d. Resistant

Career Growth Areas in Physiology / Pharmacology

Career Growth Areas in Physiology / Pharmacology Magdalena Alonso-Galicia, PhD Pharmacology Department Forest Research Institute, Inc. Jersey City, NJ 1 Career Growth Areas in BioPharma n Pharmaceutical

not to be republished NCERT BIOTECHNOLOGY AND ITS APPLICATIONS CHAPTER BIOLOGY, EXEMPLAR PROBLEMS MULTIPLE-CHOICE QUESTIONS

82 BIOLOGY, EXEMPLAR PROBLEMS CHAPTER 12 BIOTECHNOLOGY AND ITS APPLICATIONS 1. Bt cotton is not: a. A GM plant b. Insect resistant MULTIPLE-CHOICE QUESTIONS c. A bacterial gene expressing system d. Resistant

Indian biotechnology rapidly evolving and industry led

Indian biotechnology rapidly evolving and industry led Nandini K Kumar, Uyen Quach, Halla Thorsteinsdóttir, Hemlatha Somsekhar, Abdallah S Daar & Peter A Singer AFTER India became an independent nation

BIOLOGICS & PROCESS TECHNOLOGY MASTER CLASS

BIOLOGICS & PROCESS TECHNOLOGY MASTER CLASS Supported By: Organised By: PROGRAMME OVERVIEW BIOLOGICS MAKE UP MORE THAN 1,000 MEDICINES AND VACCINES THAT TARGET MORE THAN 100 DISEASES. Unlike medicines

B.Sc. DEGREE (CBSC) EXAMINATION. (Examination at the end of Sixth semester) Biochemistry. Microbiology and Molecular Biology- VII A

B.Sc. DEGREE (CBSC) EXAMINATION (Examination at the end of Sixth semester) Biochemistry Microbiology and Molecular Biology- VII A Time : Three hours Maximum : 75 marks 1. Bacterial growth curve. 2. Lytic

CONTRACTING CELL CULTURE

CONTRACTING CELL CULTURE BIOTECH EXPERIENCE Page 2 Professionals in proteins and antibodies Bayer HealthCare has more than 130 years of experience in developing and producing pharmaceuticals. An integral

THE EUROPEAN BLOOD BANKING MARKET: France, Germany, Italy, Spain, UK Emerging Opportunities and Business Expansion Strategies.

I. Introduction THE EUROPEAN BLOOD BANKING MARKET: France, Germany, Italy, Spain, UK Emerging Opportunities and Business Expansion Strategies Table of Contents II. Worldwide Technology and Market Overview

Opportunities in the India Biopharma Sector

Opportunities in the India Biopharma Sector October 2011 Anil Vaidya-Sector Specialist Life science Team UK Trade & Investment Source: Ingram Publishing/the Agency Collection/Getty Images The India Conundrum?

Pharmaceutical Reviews Year: 2008 Vol: 6 Issue: 1 ISSN: School of Pharmacy and Technology Management, NMiMS University, Mumbai

Dayanidhi B, Amol S School of Pharmacy and Technology Management, NMiMS University, Mumbai The US$65-billion (in 2005), global R&D pie is expected to grow to US$l00-billion by 2010. If India secures even

University Faculty Details Page on DU Web-site

University Faculty Details Page on DU Web-site Title Prof./Dr./Mr./Ms. First Name Vijay K. Last Chaudhary Prof. Name Designation Professor Department Biochemistry Address (Campus) University of Delhi South

Test Definition: FMEPC Meningoencephalitis (Encephalitis) Panel, CSF

Reporting Title: Meningoencephalitis Panel CSF Performing Location: Focus Diagnostics, Specimen Requirements: Submit 5 ml spinal fluid (CSF). Refrigerate specimen after collection, and ship at refrigerate

2009 INVESTOR DAY. BioPharmaceuticals. Ken Frank President BioPharmaceuticals December 17, Sustainable, Profitable Growth

2009 INVESTOR DAY BioPharmaceuticals Ken Frank President BioPharmaceuticals December 17, 2009 Sustainable, Profitable Growth Life Sciences FY 2009 Total Sales $2,329.2 (amounts shown in millions) BioPharmaceuticals

New Biological Reference Materials in 2015 Updated January 2016

New Biological Reference Materials in 2015 Updated January 2016 Part Number Part Description/ Intended use INTERNATIONAL STANDARDS AND REFERENCE PREPARATIONS 13/172 Lupus Anticoagulant (1st International

Overview of Biologics Testing and Evaluation: Regulatory Requirements and Expectations. Audrey Chang, PhD, Senior Director Development Services

Overview of Biologics Testing and Evaluation: Regulatory Requirements and Expectations Audrey Chang, PhD, Senior Director Development Services Definition of Biologics: PHS Act, section 351 Virus, therapeutic

the PLATFORM Pipeline in Lyon AREA

the PLATFORM Pipeline in Lyon AREA Do you have development or partnership projects in Life Sciences? Are you interested in developing your business in France? This overview is designed to give you an idea

INTERFACE OF NUCLEAR AND BIOTECHNOLOGIES

INTERFACE OF NUCLEAR AND BIOTECHNOLOGIES By Vienna 28 Sept. 2005 Introduction Ways in which nuclear technology has been used in recent biomedical applications. Coherent synergies between nuclear techniques

Step-by-Step Description of ELISA

Step-by-Step Description of ELISA The protocols in this kit rely on indirect antibody capture ELISA. The steps in this assay are: Step 1: Antigen is added to the wells of the microplate strip and incubated

The Integrated Biomedical Sciences Graduate Program

The Integrated Biomedical Sciences Graduate Program at the university of notre dame Cutting-edge biomedical research and training that transcends traditional departmental and disciplinary boundaries to

PHARMACEUTICALS EXPORT PROMOTION COUNCIL (Set up by Ministry of Commerce, Govt. of India)

PHARMACEUTICALS EXPORT PROMOTION COUNCIL (Set up by Ministry of Commerce, Govt. of India) COPY Date : 23-02-2010 News / Story reproduced with thanks:- Stockmarkest.com Indian pharmaceutical industry has

Examination Assignments

Bioinformatics Institute of India BIOINFORMATICS INSTITUTE OF INDIA C-56A/28, Second Floor, Sector-62, Noida-201301, UP. INDIA Tel.: 0120-4320801 / 02, M. 09818473366, 09810535368 Email: info@bii.in, Website:

Investor Overview Presentation ADVANCING LIFE SCIENCE TOGETHER

Investor Overview Presentation ADVANCING LIFE SCIENCE TOGETHER Forward-Looking Statement Disclaimer In order to take advantage of the safe harbor provisions of the private securities litigation reform

to acquire Investor And Analyst Call Presentation January 4, 2008

to acquire Investor And Analyst Call Presentation January 4, 2008 Safe Harbor Statement The following information contains, or may be deemed to contain, forward looking statements (as defined in the U.S.

Molecular Diagnostics at the Point of Need

Molecular Diagnostics at the Point of Need 24 November 2016 David Budd CEO d.budd@genedrive.com 1 DOCUMENT INFORMATION The information contained in this document and made verbally to you (together the

Global leader in predictive diagnostics ASX: PIQ

Corporate Review Sydney Canary Capital 6 th June 2017 Global leader in predictive diagnostics ASX: PIQ 1 Business model Three synergistic business areas Unifying Promarker platform technology - leverage

Enhancing Technology Transfer For Neglected Tropical Disease (NTD)

Enhancing Technology Transfer For Neglected Tropical Disease (NTD) Steven M. Ferguson, CLP Deputy Director, Licensing & Entrepreneurship Email: sf8h@nih.gov Health Research In 2013 -- Global Markets Needs

Antibody Discovery at Evotec

Antibody Discovery at Evotec - Overview - Evotec Antibodies Adding value to our partners research Innovative and flexible solutions from target ID to pre-clinical candidate The people A wide therapeutic

Technology Transfer, Academic and Industry Cooperations

Technology Transfer, Academic and Industry Cooperations Jake Micallef PhD MBA COO ValiRx plc Visiting lecturer Simfonec Jake.micallef@valirx.com What do they want? Universities Money to fund research and

BIOLOGICS & PROCESS TECHNOLOGY MASTER CLASS

BIOLOGICS & PROCESS TECHNOLOGY MASTER CLASS Supported By: Organised By: PROGRAMME OVERVIEW BIOLOGICS MAKE UP MORE THAN 1,000 MEDICINES AND VACCINES THAT TARGET MORE THAN 100 DISEASES. Unlike medicines

India's Biotechnology Plans for the Next Five Years By Biswajit Dhar and Sachin Chaturvedi

Biotechnology and Development Monitor No.35:June:1998 India's Biotechnology Plans for the Next Five Years By Biswajit Dhar and Sachin Chaturvedi Keywords: Correct citation: India; Policies/Programmes;

Company, Position & Person Profile. Cadila Healthcare Limited 6/10/15

Company, Position & Person Profile Cadila Healthcare Limited 6/10/15 About Zydus Cadila Zydus Cadila is a fully integrated, global healthcare provider, with strengths all along the pharmaceutical value

LETTERS FOR ISSUE ON

S FOR ISSUE ON 04.06.2015 LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY NO. STATUS 01 M/S. BIOMATRIX HEALTHCARE C/O. SHREE KRISHNA KESHAV, GUJARAT 26856 APPROVAL 02 M/S. AISHWARYA LIFESCIENCES, H.P.

Basic Information. I.1 If your company performs biotechnology research and development, uses a. The Categories of Biotechnology Applications.

APPENDIX 2 SURVEY QUESTIONNAIRE Part I. Basic Information I.1 If your company performs biotechnology research and development, uses a biotechnology process in manufacturing, or produces research tools,

CHAPTER 24. Immunology

CHAPTER 24 Diagnostic i Microbiology and Immunology Growth-Dependent Diagnostic Methods Isolation of Pathogens from Clinical Specimens Proper sampling and culture of a suspected pathogen is the most reliable

products. In fact, several products have been formulated and have also undergone extensive studies. These novel formulations can be used as :

Enzymes A Ray of Hope! By Shilpa Risbud, Sr Technical Manager R&D and Dr. Anita Joshi, Biotechnology Consultant For Advanced Enzyme Technologies Ltd., Thane. Published by Pharmainfo.net in Nov 2007 In

There are no secrets to success. It is the result of preparation, hard work, and learning from failure. Colin Powell

Welcome 1 2 There are no secrets to success. It is the result of preparation, hard work, and learning from failure. Colin Powell 5 FACTS about us 3 Established offers clinical Manufacturing sites Compliant

Growing Needs for Practical Molecular Diagnostics: Indonesia s Preparedness for Current Trend

Growing Needs for Practical Molecular Diagnostics: Indonesia s Preparedness for Current Trend Dr. dr. Francisca Srioetami Tanoerahardjo, SpPK., MSi Essential Practical Molecular Diagnostics Seminar Hotel

Job Title: Cell Culture Technician (open June 1 through Oct 31, 2016)

Rockland Immunochemicals Inc. is recognized as one of the world's leading manufacturers and suppliers of immunochemical reagents for basic research and discovery. Rockland Immunochemicals provides reagents

Biotechnology Overview

Biotechnology Overview What is Biotechnology? The use of living organisms to solve problems or make useful products Early Biotechnology Microbes such as yeast and bacteria to make useful food products

TRANSLATIONAL RESEARCH THEORY AND PRACTICE. Ian Weeks Professor in Translational Biochemistry School of Medicine Cardiff University

TRANSLATIONAL RESEARCH THEORY AND PRACTICE Ian Weeks Professor in Translational Biochemistry School of Medicine Cardiff University Translational research: Bench to bedside Not just clinical trials Encompasses

Pioneering Clinical Omics

Pioneering Clinical Omics Clinical Genomics Strand NGS An analysis tool for data generated by cutting-edge Next Generation Sequencing(NGS) instruments. Strand NGS enables read alignment and analysis of

Best Practices for the Use of International Standards in Vaccine Testing Dianna Wilkinson

Best Practices for the Use of International Standards in Vaccine Testing Dianna Wilkinson DCVMN Regional Training Workshop Hyderabad, 07-10 May, 2018 Biologicals substances which cannot be fully characterized

Phylogica. Harnessing Biodiversity for Peptide Therapies. Life Sciences Showcase, 23 August 2011 Nick Woolf: CFO & VP Corporate Development

Phylogica Harnessing Biodiversity for Peptide Therapies Life Sciences Showcase, 23 August 2011 Nick Woolf: CFO & VP Corporate Development Introduction Biotech company offering leading peptide drug discovery

ibio, Inc. Holds Annual Meeting in College Station, Texas

April 7, 2016 ibio, Inc. Holds Annual Meeting in College Station, Texas NEW YORK, NY -- (Marketwired) -- 04/07/16 -- ibio, Inc. (NYSE MKT: IBIO) - Speaking to shareholders at the ibio, Inc. (NYSE MKT:

Week 1: Discovery Biology Basic knowledge and tools used in Research and Development

Downing - Keio Summer School 2018 Healthcare and Biotechnology Course Outline page 1 Strand A: Healthcare and Biotechnology Course Outline This course aims to provide an overview of the current challenges

ANIMAL EXPERIMENTATION FOR HEALTH RESEARCH. Prof. M. C. Sharma Director Indian Veterinary Research Institute IZATNAGAR (UP)

ANIMAL EXPERIMENTATION FOR HEALTH RESEARCH Prof. M. C. Sharma Director Indian Veterinary Research Institute IZATNAGAR-243 122 (UP) E-mail:dirivri@ivri.res.in, directorivri@gmail.com Frontline Statement

ICH Considerations. Oncolytic Viruses September 17, 2009

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH Considerations Oncolytic Viruses September 17, 2009 1. Introduction Oncolytic viruses

Department of Genetics

Department of Genetics Program Specific Outcomes (PSO) Program- MSc. Genetics (404) The course prepares students for pursuing further research and teaching. Key features: Students have high success rate

Duncan Holmes European Head Discovery Partnerships with Academia GlaxoSmithKline

R&D Strategy Bridging g the academia-industry industry yg gap Duncan Holmes European Head Discovery Partnerships with Academia GlaxoSmithKline GSK at a glance Who we are We are a science-led global healthcare

UNLEASH THE POWER OF PRECISION MEDICINE

FROM BENCH TO BEDSIDE UNLEASH THE POWER OF PRECISION MEDICINE DCB, pioneer in biotech. Your partner in drug discovery. www.dcb.org.tw The Center for Biotechnology With over 400 dedicated researchers and

PROF. DR. ASMAA HUSSEIN DIRECTOR OF THE MOLECULAR BIOLOGY RESEARCH UNIT

BY PROF. DR. ASMAA HUSSEIN DIRECTOR OF THE MOLECULAR BIOLOGY RESEARCH UNIT Immunoassay are based on the strong and highly specific interaction occurring between antigens (Ag)) and antibodies (Ab). Ag Ab

2nd Latin American Regulatory Conference. Development of Biotechonolgy in Cuba. Dra. Diadelis Remirez Figueredo

2nd Latin American Regulatory Conference. Development of Biotechonolgy in Cuba. Dra. Diadelis Remirez Figueredo E-mail:diade.remirez@infomed.sld.cu C U B A 2004 SURFACE: 110 922 km 2 INHABITANTS: 11 254

Impact factor: /ICV: REVIEW ON BIOTECH ORIGINATE PHARMACEUTICALS Desai Kesha* 1, Shah Bhavya 2, Desai Shuchi 3, Parmar Kamlesh 4

Impact factor: 0.3397/ICV: 4.10 23 Pharma Science Monitor 6(3), Jul-Sep 2015 PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES Journal home page: http://www.pharmasm.com REVIEW

SHRM Biotechnologies Pvt Ltd

Prospectus SHRM Biotechnologies Pvt Ltd Humaipur, Abdalpur (Poddar House) Madhyamgram, Kolkata -700 155 West Bengal, India Phone +91 33 6451 1686, +91 33 2526 8988 Email: info@shrmbio.com www.shrmbio.com

Fujifilm Diosynth Biotechnologies. General Introduction

Fujifilm Diosynth Biotechnologies General Introduction October 2016 Value from Innovation Safety information Accompanied by FDB staff at all times Fire alarm. Follow host to assembly point Toxic alarm.

Presidential Commission for the Study of Bioethical Issues 2 nd meeting September

Presidential Commission for the Study of Bioethical Issues 2 nd meeting September 13 14 2010 David B. Weiner, Ph.D. Professor Department of Pathology and Laboratory Medicine University of Pennsylvania

BIOPHARMACEUTICALS Availability, Diffusion, Sustainability. Massimo Riccaboni University of Florence & CERM, Rome

BIOPHARMACEUTICALS Availability, Diffusion, Sustainability Massimo Riccaboni University of Florence & CERM, Rome The need for a precise definition of biopharmaceutical products Since the 1980s, the general

Immunological Applications. Chapter 8: Background

Immunological Applications Chapter 8: Background The Immune System Types of Immunity Innate The natural immunity present at birth Acquired A specific response to foreign substances. Some cells remember

Best Practices for the Use of International Standards in Vaccine Testing Dianna Wilkinson

Best Practices for the Use of International Standards in Vaccine Testing Dianna Wilkinson DCVMN Regional Training Workshop Hyderabad, 07-10 May, 2018 Biologicals substances which cannot be fully characterized

BioXplain The Alliance for Integrative Biology The First Open Platform for Iterative, Predictive and Integrative Biology

The Alliance for Integrative Biology The First Open Platform for Iterative, Predictive and Integrative Biology BioXplain 2009 Pharma R&D critical challenge Despite increasing investments in Technology

+ + + MALARIA HIV/AIDS TUBERCULOSIS LEISHMANIASIS CHAGAS DISEASE DENGUE EBOLA ZIKA

At the Center for Infectious Disease Research, we use systems biology approaches and cutting-edge technologies to accelerate the development of life-saving drugs, diagnostics and treatments for the world

TECHNOLOGIES AVAILABLE FOR LICENSING AT UNIVERSITY OF DELHI

TECHNOLOGIES AVAILABLE FOR LICENSING AT UNIVERSITY OF DELHI Diagnostic Technologies: Letters of Intent are invited from Industrial organizations /companies for licensing and/or up scaling of following

CURRICULUM VITAE. Educational Qualification: DEGREE INSTITUTION YEAR PROGRESS. Bharathidasan University Tamil Nadu

CURRICULUM VITAE M.BHARATH VIJAYARAGAVAN Masters in Biomedical sciences Nationality: Indian E-mail: bharathragavan@gmail.com Mobile: 91-9911738539 Sex: Male; Age: 23 Objective: Cell Signaling is an important

Medical Biotechnology Trends and Achievements in Iran

Brief Report Medical Biotechnology Trends and Achievements in Iran Fereidoun Mahboudi 1*, Haleh Hamedifar 2, and Hamideh Aghajani 3 1. Biotechnology Research Center, Pasteur Institute of Iran, Tehran Iran